Payer

Medicare Advantage enrollment now represents half of total Medicare enrollment, according to a May 1 analysis from the Kaiser Family Foundation. 

Centene shareholders will vote on a pair of proposals that take aim at executive pay, the St. Louis Post-Dispatch reported May 9. 

A Connecticut medical practice's lawsuit alleging Centene failed to reimburse it for COVID-19 testing services has been thrown out after the practice missed a deadline to refile the case. 

New GLP-1 drugs to treat Type 2 diabetes and obesity can be expensive, but payer leaders said the costs aren't breaking the bank yet. 

More data is necessary to evaluate the quality of care Medicare Advantage beneficiaries with serious illnesses receive, a group of researchers wrote in the New England Journal of Medicine. 

Cigna posted the largest membership growth of prominent payer companies in the first quarter of 2023. 

Employers are hesitant to cover the cost of GLP-1 drugs for their employees, the Cigna Group CEO David Cordani said. 

From the release of its first-quarter earnings, to launching new Medicare Advantage special needs plans, here are eight updates about Humana that Becker's has reported since April 20:

Federal Medicaid work requirements could cost states up to $10.3 billion each year if they chose to maintain coverage for people no longer federally eligible for the program, according to an analysis from Kaiser Family Foundation. 

Alignment Healthcare upped its year-over-year revenue and improved on losses in the first quarter of 2023.